Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03517163 · ClinicalTrials.gov registry record
Boston Outcomes of Autism in Toddlers Study
A clinical trial, sponsored by Boston Children's Hospital.
- Completed
- Registry status
- 225
- Enrollment target
NCT03517163: Completed study, sponsored by Boston Children's Hospital.
NCT03517163 is a clinical trial that has completed, run by Boston Children's Hospital. The registered enrollment target is 225 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03517163 has completed, sponsored by Boston Children's Hospital.
- COMPLETED
- Registry status
- 225 participants
- Enrollment target
Study Summary
The purpose of this research study is to learn more about the outcomes of children who received an Autism Spectrum Disorder (ASD) diagnosis when they were toddlers. The study is interested in whether an early diagnosis can help children with their cognitive, language, social, and behavioral abilities.
Primary Outcome
The severity of ASD symptoms in the child (Autism Diagnostic Observation Schedule and Autism Diagnostic Interview-Revised)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 225 participants |
| Start Date | 2018-06-01 |
| Est. Completion | 2022-01-01 |
What the finished NCT03517163 record still lists
NCT03517163 is an observational study that tracks outcomes without assigning an intervention. The registered 225 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT03517163 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03517163 about?
NCT03517163 is a clinical study titled "Boston Outcomes of Autism in Toddlers Study". The purpose of this research study is to learn more about the outcomes of children who received an Autism Spectrum Disorder (ASD) diagnosis when they were toddlers. The study is interested in whether an early diagnosis can help children with their cognitive, language, social, and behavioral abilitie...
What is the current status of trial NCT03517163?
This trial is currently completed. The enrollment target is 225 participants. The study started on 2018-06-01. Estimated completion is 2022-01-01.
Who is sponsoring clinical trial NCT03517163?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03955445 · 225 participants · Phase 3
Long-term Efficacy, Safety and Tolerability of Iptacopan in C3G or IC-MPGN
- NCT04054310 · 225 participants · NA
Non-Invasive Quantification of Liver Health in NASH (N-QUAN)
- NCT04480554 · 225 participants · Phase 2
Anti-retroviral Therapy, Medications for Opioid Use Disorder, Opioids and HIV Infection - Study 1
- NCT04888104 · 225 participants
Prospective, Multicenter, Case-Control Analysis of the VersaTie Posterior Fixation System to Prevent Proximal Junctional Failure in Long Posterior Spinal Fusion Constructs for Adult Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI